Eiger BioPharmaceuticals (EIGR) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free EIGR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 1, 2024 | wsj.comFirm Retention Summary: Eiger BioPharmaceuticalsApril 8, 2024 | wsj.comRequiem for Eiger BiopharmaceuticalsApril 2, 2024 | bizjournals.comPeninsula biotech files for Chapter 11 bankruptcy protectionApril 1, 2024 | wsj.comEiger BioPharmaceuticals Files for BankruptcyApril 1, 2024 | marketwatch.comHealthcare stocks fade as obesity-drug optimism fadesApril 1, 2024 | msn.comMetabolic Diseases-Focused Eiger BioPharmaceuticals Files For Bankruptcy, Stock NosedivesApril 1, 2024 | finance.yahoo.comEiger Biopharmaceuticals Files for Chapter 11 BankruptcyApril 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 12:04 PM. April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 12:04 PM with a stated reason of "LULD pause."April 1, 2024 | msn.comEiger reportedly files for Chapter 11, stock plunges 52%April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause." Trading set to resume at 11:04 AM. April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 11:04 AM with a stated reason of "LULD pause."April 1, 2024 | globenewswire.comEiger BioPharmaceuticals Files for Voluntary Chapter 11 ProtectionApril 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause." Trading set to resume at 10:04 AM. April 1, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 10:04 AM with a stated reason of "LULD pause."March 20, 2024 | seekingalpha.comEIGR Eiger BioPharmaceuticals, Inc.March 4, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 09:03 AM with a stated reason of "LULD pause."February 8, 2024 | bizjournals.comNew Natomas industrial property owner Eiger Capital could be buying more local assetsFebruary 4, 2024 | bizjournals.comPanattoni sells part of Natomas Advanced Logistics Center to Eiger CapitalJanuary 18, 2024 | finance.yahoo.comEiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in JapanJanuary 8, 2024 | marketbeat.comTrading was temporarily halted for "EIGR" at 07:01 PM with a stated reason of "News pending."January 4, 2024 | msn.comEiger BioPharmaceuticals announces 1-for-30 reverse stock splitJanuary 4, 2024 | finance.yahoo.comEiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock SplitDecember 7, 2023 | yahoo.com‘Bob Eiger’ Trends on X After Elon Musk Blasts the Disney CEO With Multi-Tweet TypoDecember 4, 2023 | finance.yahoo.comEiger BioPharmaceuticals Insiders US$2.1m Short Of Breakeven On Stock PurchaseNovember 11, 2023 | finanznachrichten.deEiger BioPharmaceuticals, Inc.: Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateSeptember 15, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Ocular Therapeutix (OCUL), Eiger Biopharmaceuticals (EIGR)September 13, 2023 | marketwatch.comEiger BioPharmaceuticals Shares Hit New Lows After Scrapped Hepatitis D StudySeptember 13, 2023 | markets.businessinsider.comEiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In PremarketSeptember 13, 2023 | msn.comWhy Is Hepatitis Player Eiger BioPharma Stock Trading Lower Today?September 13, 2023 | investorplace.comWhy Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?September 13, 2023 | reuters.comEiger to discontinue late-stage hepatitis drug study over safety concernsSeptember 12, 2023 | news.yahoo.comEiger to discontinue hepatitis drug study over safety concernsSeptember 12, 2023 | marketwatch.comEiger BioPharmaceuticals to Discontinue Chronic Hepatitis Delta Study, Ends Licensing TalksSeptember 12, 2023 | seekingalpha.comEiger to stop late stage trial in hepatitis D patients, stock slumps ~36% after hoursSeptember 12, 2023 | finance.yahoo.comUPDATE 1-Eiger to discontinue hepatitis drug study over safety concernsSeptember 12, 2023 | reuters.comEiger to discontinue hepatitis drug studySeptember 12, 2023 | marketbeat.comTrading was temporarily halted for "EIGR" at 04:09 PM with a stated reason of "News pending."August 30, 2023 | markets.businessinsider.comCiti Sticks to Their Buy Rating for Eiger Biopharmaceuticals (EIGR)August 15, 2023 | finanznachrichten.deEiger BioPharmaceuticals, Inc.: Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 15, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR) and Atossa Therapeutics (ATOS)August 14, 2023 | markets.businessinsider.comEiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateAugust 3, 2023 | yahoo.comFreewell Eiger matte box aims to transform your filmmakingJuly 6, 2023 | msn.comEiger BioPharmaceuticals (EIGR) Price Target Decreased by 59.60% to 3.40July 1, 2023 | msn.comBaird Maintains Eiger BioPharmaceuticals (EIGR) Outperform RecommendationJune 30, 2023 | markets.businessinsider.comPotential Upside For Eiger's Avexitide In Both PBH And CHI Indications: Analyst Get Eiger BioPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. EIGR Media Mentions By Week EIGR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EIGR News Sentiment▼0.000.78▲Average Medical News Sentiment EIGR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EIGR Articles This Week▼01▲EIGR Articles Average Week Get Eiger BioPharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for EIGR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kaleido Biosciences News Today Virios Therapeutics News Today Humanigen News Today Alpha Tau Medical News Today Artelo Biosciences News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Voyager Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EIGR) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eiger BioPharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.